133 related articles for article (PubMed ID: 2000790)
1. Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study).
Am J Cardiol; 1991 Mar; 67(7):578-84. PubMed ID: 2000790
[TBL] [Abstract][Full Text] [Related]
2. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators.
Am J Cardiol; 1993 Aug; 72(3):280-7. PubMed ID: 8342505
[TBL] [Abstract][Full Text] [Related]
3. The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators.
Greene HL
Am J Cardiol; 1993 Nov; 72(16):70F-74F. PubMed ID: 8237833
[TBL] [Abstract][Full Text] [Related]
4. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
Steinbeck G; Greene HL
Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
[TBL] [Abstract][Full Text] [Related]
5. Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
Anderson JL
J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):880-6. PubMed ID: 8548109
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
[TBL] [Abstract][Full Text] [Related]
7. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
Singh BN
Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes.
Tsai CF; Chen SA; Tai CT; Chiang CE; Ding YA; Chang MS
Int J Cardiol; 1998 Mar; 64(1):47-55. PubMed ID: 9579816
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S
Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883
[TBL] [Abstract][Full Text] [Related]
12. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Cairns JA; Connolly SJ; Roberts R; Gent M
Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
[TBL] [Abstract][Full Text] [Related]
13. Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring.
Skale BT; Miles WM; Heger JJ; Zipes DP; Prystowsky EN
Am J Cardiol; 1986 Jan; 57(1):113-9. PubMed ID: 3942053
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Heger JJ; Prystowsky EN; Zipes DP
Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
[TBL] [Abstract][Full Text] [Related]
16. Rehospitalization in surviving patients of out-of-hospital ventricular fibrillation (the CASCADE Study). Cardiac Arrest in Seattle: Conventional Amiodarone Drug Evaluation.
Maynard C
Am J Cardiol; 1993 Dec; 72(17):1295-300. PubMed ID: 8256707
[TBL] [Abstract][Full Text] [Related]
17. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
18. Control of sudden recurrent arrhythmic deaths: role of amiodarone.
Nademanee K; Singh BN; Cannom DS; Weiss J; Feld G; Stevenson WG
Am Heart J; 1983 Oct; 106(4 Pt 2):895-901. PubMed ID: 6613836
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of patients with sustained ventricular tachycardia and of survivors of cardiac arrest not inducible by programmed stimulation.
Andresen D; Steinbeck G; Brüggemann T; Haberl R; Fink L; Schröder R
Am J Cardiol; 1992 Nov; 70(15):1250-4. PubMed ID: 1442574
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.
Proclemer A; Facchin D; Vanuzzo D; Feruglio GA
Cardiovasc Drugs Ther; 1993 Aug; 7(4):683-9. PubMed ID: 8241012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
